Literature DB >> 31764759

Quantitative Blood Loss in Obstetric Hemorrhage: ACOG COMMITTEE OPINION, Number 794.

.   

Abstract

Postpartum hemorrhage causes approximately 11% of maternal deaths in the United States and is the leading cause of death that occurs on the day of birth. Importantly, 54-93% of maternal deaths due to obstetric hemorrhage may be preventable. Studies that have evaluated factors associated with identification and treatment of postpartum hemorrhage have found that imprecise health care provider estimation of actual blood loss during birth and the immediate postpartum period is a leading cause of delayed response to hemorrhage. Although current data do not support any one method of quantifying blood loss as superior to another, quantification of blood loss, such as using graduated drapes or weighing, provides a more accurate assessment of actual blood loss than visual estimation; however, the effectiveness of quantitative blood loss measurement on clinical outcomes has not been demonstrated. Successful obstetric hemorrhage bundle implementation is associated with improved outcome measures related to obstetric hemorrhage. However, further research is necessary to better evaluate the particular effect of quantitative blood loss measurement in reducing maternal hemorrhage- associated morbidity in the United States.

Entities:  

Mesh:

Year:  2019        PMID: 31764759     DOI: 10.1097/AOG.0000000000003564

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  Diagnostic value of fibrinogen combined with thromboelastogram in postpartum hemorrhage after vaginal delivery.

Authors:  Xiaojuan Zhu; Jie Tang; Xiaohong Huang; Ying Zhou
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Midwives' ability during third stage of childbirth to estimate postpartum haemorrhage.

Authors:  Ingela Wiklund; Soledad Alarcón Fernández; Markus Jonsson
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2022-07-03

3.  Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial.

Authors:  Wirawan Sringamwong; Surasak Saokaew; Pajaree Mongkhon
Journal:  Ann Med Surg (Lond)       Date:  2022-06-04

4.  Effect of implementation of a colorimetric quantitative blood loss system for postpartum hemorrhage.

Authors:  Maryalice Wolfe; Jamil M Kazma; Ann B Burke; Homa K Ahmadzia
Journal:  Int J Gynaecol Obstet       Date:  2022-04-16       Impact factor: 4.447

5.  A prospective cohort study of shock index as a reliable marker to predict the patient's need for blood transfusion due to postpartum hemorrhage.

Authors:  Suleyman Cemil Oglak; Mehmet Obut; Ali Emre Tahaoglu; Neslihan Ugur Demirel; Bekir Kahveci; Ihsan Bagli
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

6.  Effects of Fu Fang Yi Mu Cao capsules combined with Yiqi Xiaoyu decoction on lochia.

Authors:  Liqiao Zhang; Chunyan Yang; Wei Dong; Yaqing Du; Ruiping Wang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

7.  Measurement of postpartum blood loss using a new two-set liquid collection bag for vaginal delivery: A prospective, randomized, case control study.

Authors:  Fang Wang; Nanjia Lu; Xiaofeng Weng; Yanping Tian; Shiwen Sun; Baohua Li
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

8.  Limitations of Gravimetric Quantitative Blood Loss during Cesarean Delivery.

Authors:  Robert L Thurer; Sahar Doctorvaladan; Brendan Carvalho; Andrea T Jelks
Journal:  AJP Rep       Date:  2022-02-04

9.  Effectiveness of emergency obstetric care training at the regional level in Ukraine: a non-randomized controlled trial.

Authors:  Iryna Mogilevkina; Vitaliy Gurianov; Gunilla Lindmark
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-22       Impact factor: 3.007

10.  Postpartum hemorrhage risk is driven by changes in blood composition through pregnancy.

Authors:  Matthew R Robinson; Marion Patxot; Miloš Stojanov; Sabine Blum; David Baud
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.